{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:17Z","timestamp":1772119697248,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T00:00:00Z","timestamp":1218153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s10840-008-9290-6","type":"journal-article","created":{"date-parts":[[2008,8,7]],"date-time":"2008-08-07T14:00:05Z","timestamp":1218117605000},"page":"111-115","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter"],"prefix":"10.1007","volume":"23","author":[{"given":"Javier E.","family":"Banchs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L.","family":"Wolbrette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya M.","family":"Samii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica D.","family":"Penny-Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parag P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sallie K.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario D.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald V.","family":"Naccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,8]]},"reference":[{"key":"9290_CR1","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"V. Fuster","year":"2006","unstructured":"Fuster, V., Ryden, L. E., Cannom, D. S., et al. (2006). ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation, 114, e257\u2013e354.","journal-title":"Circulation"},{"key":"9290_CR2","first-page":"318","volume":"256","author":"M. Gwilt","year":"1991","unstructured":"Gwilt, M., Arrowsmith, J. E., Blackburn, K. J., et al. (1991). UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. The Journal of Pharmacology and Experimental Therapeutics, 256, 318\u2013324.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"9290_CR3","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/01.CIR.102.21.2665","volume":"102","author":"J. P. Mounsey","year":"2000","unstructured":"Mounsey, J. P., & DiMarco, J. P. (2000). Cardiovascular drugs. Dofetilide. Circulation, 102, 2665\u20132670.","journal-title":"Circulation"},{"issue":"1","key":"9290_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14779072.5.1.9","volume":"5","author":"H. Roukoz","year":"2007","unstructured":"Roukoz, H., & Saliba, W. (2007). Dofetilide: a new class III antiarrhythmic agent. Expert Review of Cardiovascular Therapy, 5(1), 9\u201319.","journal-title":"Expert Review of Cardiovascular Therapy"},{"key":"9290_CR5","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1161\/01.CIR.99.19.2486","volume":"99","author":"R. A. Greenbaum","year":"1999","unstructured":"Greenbaum, R. A. (1999). Meeting highlights: highlights of the 71st Scientific Sessions of the American Heart Association. The EMERALD trial. Circulation, 99, 2486\u20132491.","journal-title":"Circulation"},{"key":"9290_CR6","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","volume":"102","author":"S. Singh","year":"2000","unstructured":"Singh, S., Zoble, R. G., Yellen, L., et al. (2000). Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on defetilide (SAFIRE-D) study. Circulation, 102, 2385\u20132390.","journal-title":"Circulation"},{"key":"9290_CR7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","volume":"341","author":"C. Torp-Pedersen","year":"1999","unstructured":"Torp-Pedersen, C., Moller, M., Bloch-Thomsen, P. E., et al. (1999). Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. The New England Journal of Medicine, 341, 857\u2013865.","journal-title":"The New England Journal of Medicine"},{"key":"9290_CR8","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(00)03402-4","volume":"356","author":"L. Kober","year":"2000","unstructured":"Kober, L., Bloch Thompsen, P. E., Moller, M., et al. (2000). Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction: a randomized trial. Lancet, 356, 2052\u20132058.","journal-title":"Lancet"},{"key":"9290_CR9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","volume":"104","author":"O. D. Pedersen","year":"2001","unstructured":"Pedersen, O. D., Bagger, H., Keller, N., & Marchant, B. (2001). kober l, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation\u2013flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation, 104, 292\u2013296.","journal-title":"Circulation"},{"key":"9290_CR10","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1046\/j.1540-8167.2003.90402.x","volume":"14","author":"E. N. Prystowsky","year":"2003","unstructured":"Prystowsky, E. N., Freeland, S., Branyas, N. A., et al. (2003). Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14, S287\u2013S290.","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"9290_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1074248407299272","volume":"12","author":"A. Mykytsey","year":"2007","unstructured":"Mykytsey, A., Bauman, J. L., Razminia, M., et al. (2007). Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. Journal of Cardiovascular Pharmacology and Therapeutics, 12, 36\u201343.","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"key":"9290_CR12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1540-8159.2007.00902.x","volume":"30","author":"D. Cotiga","year":"2007","unstructured":"Cotiga, D., Arshad, A., Aziz, E., et al. (2007). Acute conversion of persistent atrial fibrillation during dofetilide initiation. Pacing and Clinical Electrophysiology, 30, 1527\u20131530.","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"3","key":"9290_CR13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/107424849700200306","volume":"2","author":"G. K. Feld","year":"1997","unstructured":"Feld, G. K., & Cha, Y. (1997). Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide in an experimental canine model of pacing-induced atrial fibrillation. Journal of Cardiovascular Pharmacology and Therapeutics, 2(3), 195\u2013203.","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"key":"9290_CR14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1460-9592.2001.00824.x","volume":"24","author":"C. T. Tai","year":"2001","unstructured":"Tai, C. T., & Chen, S. A. (2001). Mechanisms of antiarrhythmic drug action on termination of atrial flutter. Pacing and Clinical Electrophysiology, 24, 824\u2013834.","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"2","key":"9290_CR15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0735-1097(96)00506-2","volume":"29","author":"R. H. Falk","year":"1997","unstructured":"Falk, R. H., Pollak, A., Singh, S. N., et al. (1997). Intravenous dofetilide a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. Journal of the American College of Cardiology, 29(2), 385\u2013390.","journal-title":"Journal of the American College of Cardiology"},{"key":"9290_CR16","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1161\/01.CIR.96.12.4298","volume":"96","author":"B. S. Stambler","year":"1997","unstructured":"Stambler, B. S., Wood, M. A., & Ellenbogen, K. A. (1997). Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Electrophysiological determinants of enhanced conversion efficacy. Circulation, 96, 4298\u20134306.","journal-title":"Circulation"},{"key":"9290_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s002100000328","volume":"363","author":"K. J. Wirth","year":"2001","unstructured":"Wirth, K. J., & Knobloch, K. (2001). Differential effects of dofetilide, amiodarone, and class Ic drugs on left and right atrial refractoriness and left atrial vulnerability in pigs. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 363, 166\u2013174.","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"9290_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00210-002-0599-x","volume":"366","author":"K. Knobloch","year":"2002","unstructured":"Knobloch, K., Brendel, J., Peukert, S., et al. (2002). Electrophysiological and antiarrhythmic effects of the novel Ikur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the IKr blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 366, 482\u2013487.","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"9290_CR19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0008-6363(01)00549-1","volume":"54","author":"A. L. Waldo","year":"2002","unstructured":"Waldo, A. L. (2002). Mechanisms of atrial flutter and atrial fibrillation: distinct entities or two sides of a coin. Cardiovascular Research, 54, 216\u2013229.","journal-title":"Cardiovascular Research"},{"key":"9290_CR20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2007.08.066","volume":"51","author":"A. L. Waldo","year":"2008","unstructured":"Waldo, A. L., & Feld, G. K. (2008). Inter-relationships of atrial fibrillation and atrial flutter. Journal of the American College of Cardiology, 51, 779\u2013786.","journal-title":"Journal of the American College of Cardiology"},{"key":"9290_CR21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","volume":"111","author":"R. Cappato","year":"2005","unstructured":"Cappato, R., Calkins, H., Chen, S. A., et al. (2005). Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation, 111, 1100\u20131105.","journal-title":"Circulation"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-008-9290-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-008-9290-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-008-9290-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:03:56Z","timestamp":1559253836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-008-9290-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9290"],"URL":"https:\/\/doi.org\/10.1007\/s10840-008-9290-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725450184.793506287","asserted-by":"object"}]},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,8]]}}}